10 Best Stocks to Buy for a Quick Return
The stock market is made up of thousands of stocks, belonging to a wide variety of industries and sectors.
Summit Therapeutics Inc. (SMMT)
Market is closed
News
- First
- << Previous
- 31 - 40
- Next >>
Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is Brent, and I will be your conference operator today.
Hedge Fund and Insider Trading News: Angelo Gordon & Co., Elliott Management, Haidar Jupiter Fund, Antara Capital, Uniti Group Inc (UNIT), Occidental Petroleum Corporation (OXY), and More
Elliott Management has made it through to the second stage of the Manchester United bidding process but the Glazer family remain undecided on selling the club.
5 Penny Stocks with Insider Buying
Franklin Street Properties Corp. (NYSE:FSP) is a real estate investment trust (REIT) that is headquartered in Wakefield, Massachusetts.
10 Best Penny Stocks to Buy in September
In this article, we will take a look at the 10 best penny stocks to buy in September.
Hedge Fund and Insider Trading News: Anthony Scaramucci, Michael Burry, Ken Griffin, Tudor Jones, Third Point LLC, Oasis Management, Sarepta Therapeutics Inc (SRPT), Summit Therapeutics Inc. (SMMT), and More
The selloff in crypto, as well as the broader market downturn, has left Anthony Scaramucci’s SkyBridge Capital’s flagship fund of funds down 25 percent for the year through the end of July.
Is Summit Therapeutics PLC (SMMT) A Good Stock To Buy?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
13D Filing: Lansdowne Partners and Summit Therapeutics PLC (ADR) (SMMT)
Summit Therapeutics PLC (ADR) (NASDAQ:SMMT): Alex Snow's Lansdowne Partners filed an amended 13D.
You can check out Lansdowne Partners' latest holdings and filings here.
Market Movers Today: Iovance Biotherapeutics Inc (IOVA), Key Technology, Inc. (KTEC), Union Pacific Corporation (UNP), and More
What happened: Shares of pre-revenue biopharma Iovance Biotherapeutics (NASDAQ:IOVA) rose nearly 30% today after the company announced preliminary results from two phase 2 trials evaluating one of its...
13D Filing: Lansdowne Partners and Summit Therapeutics PLC (ADR) (SMMT)
Summit Therapeutics PLC (ADR) (NASDAQ:SMMT): Alex Snow's Lansdowne Partners filed an amended 13D.
You can check out Lansdowne Partners' latest holdings and filings here.
- First
- << Previous
- 31 - 40
- Next >>
Billionaire Hedge Funds
